Stock Report

Suven Life Sciences Ltd Q2FY22 consolidated loss at Rs. 28.29 crore

Posted On : 2021-10-25 13:25:12( TIMEZONE : IST )

Suven Life Sciences Limited has reported Consolidated financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 1.6869 crores during the period ended September 30, 2021 as compared to Rs. 6.5613 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. -28.2982 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. -39.2085 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. -2.22 for the period ended September 30, 2021 as compared to Rs. -3.08 for the period ended June 30, 2021.

Financials	Q2 FY2022	Q1 FY2022	% Change
Total Income	₹ 1.6869 crs	₹6.5613 crs	-74.29%
Net Profit	₹-28.2982 crs	₹-39.2085 crs	27.83%
EPS	₹-2.22	₹-3.08	27.92%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 1.6869 crores during the period ended September 30, 2021 as compared to Rs.11.2568 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.-28.2982 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.-15.6566 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.-2.22 for the period ended September 30, 2021 as compared to Rs.-1.23 for the period ended September 30, 2020.

Financials	Q2 FY2022	Q2 FY2021	% Change
Total Income	₹ 1.6869 crs	₹11.2568 crs	-85.01%
Net Profit	₹-28.2982 crs	₹-15.6566 crs	80.74%
EPS	₹-2.22	₹-1.23	80.49%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.8.2482 crores during the 6 Months period ended September 30, 2021 as compared to Rs.15.2147 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.-67.5067 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.-26.14559 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.-5.30 for the 6 Months period ended September 30, 2021 as compared to Rs.-2.05 for the 6 Months period ended September 30, 2020.

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹8.2482 crs	₹15.2147 crs	-45.79%
Net Profit	₹-67.5067 crs	₹-26.14559 crs	158.20%
EPS	₹-5.30	₹-2.05	158.54%

Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 110.80 as compared to the previous close of Rs. 100.95. The total number of shares traded during the day was 263386 in over 4659 trades.

The stock hit an intraday high of Rs. 116.30 and intraday low of 102.75. The net turnover during the day was Rs. 28918671.00.